{"article_url":"https://newsverum.com/en/news/johnson-and-johnson-tremfya-phase-4-star-axial-psoriatic-arthritis-2026","block":{"description":{"ar":"أرقام مختارة للفعالية وعدد المشاركين عند الأسبوع 24 من دراسة STAR للمرحلة الرابعة لدواء TREMFYA.","de":"Ausgewählte Wirksamkeitsdaten zu Woche 24 und Teilnehmerzahlen aus der Phase-4-Studie STAR zu TREMFYA.","en":"Selected Week 24 efficacy and enrolment figures from the Phase 4 STAR study of TREMFYA in axial psoriatic arthritis.","es":"Cifras seleccionadas de eficacia en la semana 24 y reclutamiento del estudio de fase 4 STAR de TREMFYA.","fr":"Chiffres sélectionnés d'efficacité à la semaine 24 et d'inclusion issus de l'étude de phase 4 STAR de TREMFYA.","pt":"Valores selecionados de eficácia na semana 24 e recrutamento do estudo de fase 4 STAR do TREMFYA.","tr":"Aksiyel psoriatik artritte TREMFYA Faz 4 STAR çalışmasından seçilmiş 24. hafta etkinlik ve katılım rakamları."},"id":"reported-figures","items":[{"basis":"observed","label":{"ar":"عدد المشاركين العالميين المسجلين في دراسة STAR للمرحلة الرابعة","de":"Weltweit eingeschlossene Teilnehmer in der Phase-4-Studie STAR","en":"Global participants enrolled in Phase 4 STAR study","es":"Participantes reclutados a nivel mundial en el estudio de fase 4 STAR","fr":"Participants recrutés dans le monde dans l'étude de phase 4 STAR","pt":"Participantes recrutados a nível mundial no estudo de fase 4 STAR","tr":"Faz 4 STAR çalışmasına dünya genelinde katılan hasta sayısı"},"measure":{"aggregation":"stock","frequency":"irregular","geography":"world","id":"g20261120-d7-jnj-1","periodRole":"announcement-date","unitCode":"count"},"period":"2026-11-20","unit":"patients","value":411},{"basis":"observed","label":{"ar":"متوسط التغير في مؤشر BASDAI عند الأسبوع 24 مع TREMFYA كل أربعة أسابيع","de":"Mittlere BASDAI-Änderung in Woche 24 unter TREMFYA alle 4 Wochen","en":"Mean Week 24 BASDAI score change with TREMFYA Q4W","es":"Cambio medio en BASDAI en la semana 24 con TREMFYA cada 4 semanas","fr":"Variation moyenne du score BASDAI à la semaine 24 avec TREMFYA toutes les 4 semaines","pt":"Variação média do BASDAI na semana 24 com TREMFYA a cada 4 semanas","tr":"Dört haftada bir TREMFYA ile 24. hafta ortalama BASDAI puan değişimi"},"measure":{"aggregation":"change","frequency":"irregular","geography":"world","id":"g20261120-d7-jnj-2","periodRole":"announcement-date","unitCode":"index-point"},"period":"2026-11-20","unit":"points","value":-3.3},{"basis":"observed","label":{"ar":"متوسط التغير في مؤشر BASDAI عند الأسبوع 24 مع TREMFYA كل ثمانية أسابيع","de":"Mittlere BASDAI-Änderung in Woche 24 unter TREMFYA alle 8 Wochen","en":"Mean Week 24 BASDAI score change with TREMFYA Q8W","es":"Cambio medio en BASDAI en la semana 24 con TREMFYA cada 8 semanas","fr":"Variation moyenne du score BASDAI à la semaine 24 avec TREMFYA toutes les 8 semaines","pt":"Variação média do BASDAI na semana 24 com TREMFYA a cada 8 semanas","tr":"Sekiz haftada bir TREMFYA ile 24. hafta ortalama BASDAI puan değişimi"},"measure":{"aggregation":"change","frequency":"irregular","geography":"world","id":"g20261120-d7-jnj-3","periodRole":"announcement-date","unitCode":"index-point"},"period":"2026-11-20","unit":"points","value":-2.9},{"basis":"observed","label":{"ar":"متوسط التغير في مؤشر SPARCC بالرنين المغناطيسي عند الأسبوع 24 مع TREMFYA كل أربعة أسابيع","de":"Mittlere SPARCC-MRT-Änderung in Woche 24 unter TREMFYA alle 4 Wochen","en":"Mean Week 24 SPARCC MRI score change with TREMFYA Q4W","es":"Cambio medio en SPARCC por resonancia en la semana 24 con TREMFYA cada 4 semanas","fr":"Variation moyenne du score IRM SPARCC à la semaine 24 avec TREMFYA toutes les 4 semaines","pt":"Variação média do SPARCC em ressonância na semana 24 com TREMFYA a cada 4 semanas","tr":"Dört haftada bir TREMFYA ile 24. hafta ortalama SPARCC MR puan değişimi"},"measure":{"aggregation":"change","frequency":"irregular","geography":"world","id":"g20261120-d7-jnj-4","periodRole":"announcement-date","unitCode":"index-point"},"period":"2026-11-20","unit":"points","value":-7.1},{"basis":"observed","label":{"ar":"متوسط التغير في مؤشر SPARCC بالرنين المغناطيسي عند الأسبوع 24 مع العلاج الوهمي","de":"Mittlere SPARCC-MRT-Änderung in Woche 24 unter Placebo","en":"Mean Week 24 SPARCC MRI score change with placebo","es":"Cambio medio en SPARCC por resonancia en la semana 24 con placebo","fr":"Variation moyenne du score IRM SPARCC à la semaine 24 sous placebo","pt":"Variação média do SPARCC em ressonância na semana 24 com placebo","tr":"Plasebo ile 24. hafta ortalama SPARCC MR puan değişimi"},"measure":{"aggregation":"change","frequency":"irregular","geography":"world","id":"g20261120-d7-jnj-5","periodRole":"announcement-date","unitCode":"index-point"},"period":"2026-11-20","unit":"points","value":-2.4}],"methodology":{"ar":"تحتفظ الأرقام بنقاط النهاية وأذرع الجرعات والتعريفات التي يحددها المصدر، وتشير التغيرات السالبة في الدرجات إلى تراجع الأعراض أو الالتهاب مقارنة بخط الأساس.","de":"Die Zahlen behalten Endpunkte, Dosierungsarme, Population und Definitionen der Quelle bei. Negative Punktänderungen zeigen eine Abnahme von Beschwerden oder Entzündung an.","en":"Figures retain the source's stated endpoints, dosing arms, population and definitions. Negative score changes denote symptom or inflammation reduction from baseline. No missing value is inferred.","es":"Las cifras conservan los criterios, brazos de dosificación, población y definiciones indicados por la fuente. Los cambios negativos reflejan reducción de síntomas o inflamación.","fr":"Les chiffres conservent les critères, bras de posologie, populations et définitions indiqués par la source. Les variations négatives traduisent une baisse des symptômes ou de l'inflammation.","pt":"Os valores mantêm os parâmetros, braços posológicos, população e definições indicados pela fonte. Variações negativas indicam redução de sintomas ou inflamação.","tr":"Rakamlar kaynağın belirttiği sonlanım noktaları, doz kolları, nüfus ve tanımları korur. Negatif puan değişimleri başlangıca göre belirti veya iltihap azalmasını gösterir. Eksik değerler çıkarımla tamamlanmaz."},"sourceUrls":["https://www.prnewswire.com/news-releases/johnson--johnson-data-in-psoriatic-arthritis-psa-shows-tremfya-guselkumab-is-the-only-advanced-therapy-to-demonstrate-mri-confirmed-improvements-in-spinal-pain-and-stiffness-302946249.html"],"title":{"ar":"الأرقام الرئيسية المعلنة","de":"Wichtige gemeldete Kennzahlen","en":"Key reported figures","es":"Cifras clave comunicadas","fr":"Principaux chiffres déclarés","pt":"Principais valores reportados","tr":"Bildirilen temel rakamlar"},"type":"metrics","updatedAt":"2026-11-20T14:30:00Z"},"version":1}
